Bristol-Myers SquibbBristol-Myers Squibb is joining the world community in providing immediate help for survivors of the massive earthquake that struck Haiti on January 12. The company has already shipped a large donation of antibiotics through Project Hope, an organization providing direct relief to disaster victims. In addition, Bristol-Myers Squibb France is sending medicine to help the injured through Tulipe, an organization that facilitates pharmaceutical company donations to provide an emergency response to people in distress as a result of acute health crises, natural disasters or conflicts.

In addition to the medicines the company has shipped or is sending to help the injured, the Bristol-Myers Squibb Foundation will donate a total of $200,000 to three organizations providing disaster relief. The organizations are:

  • The Catholic Medical Mission Board, which has been working in Haiti since 1912 to provide medicines and much needed supplies and support;
  • The American Red Cross, which is giving $10 million to support a number of relief efforts in the country, many already under way; and
  • Partners in Health, which has been working in Haiti since 1987 to address health care needs.

The Bristol-Myers Squibb Foundation will match two-for-one contributions made by employees in the U.S. and Puerto Rico to the following organizations assisting disaster relief efforts in Haiti:

  • AmeriCares
  • American Red Cross
  • CARE
  • Catholic Medical Mission Board
  • Direct Relief International
  • Doctors Without Borders
  • Partners in Health
  • Project Hope
  • Save the Children

Bristol-Myers Squibb will continue to monitor the situation with its relief partners.

About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines that help patients prevail over serious diseases. For more information, please visit